Role of long non-coding RNA in drug resistance in non-small cell lung cancer

Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer

(2018) Banglun Qian et al.   Thoracic Cancer

Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2

(2017) Yuchun Niu et al.   Molecular Cancer

Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway

(2017) Hui Shi et al.   TUMOR BIOLOGY

LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis

(2017) Pei Wang et al.   OncoTargets and Therapy

Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway

(2017) Bing Wang et al.   Oncology Letters

Knockdown of long non-coding RNA Taurine Up-Regulated 1 inhibited doxorubicin resistance of bladder urothelial carcinoma via Wnt/β-catenin pathway

(2017) Dalong Xie et al.   Oncotarget

LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling

(2017) Shurui Ouyang et al.   Oncotarget

Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma

(2017) Shicheng Li et al.   Thoracic Cancer

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Risk factors and management of oligometastatic non-small cell lung cancer

(2016) Akshar N. Patel et al.   Therapeutic Advances in Respiratory Disease

The cross talk between long, non-coding RNAs and microRNAs in gastric cancer

(2015) Kaiyuan Deng et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

A BRCA1-interacting lncRNA regulates homologous recombination

(2015) V. Sharma et al.   EMBO REPORTS

The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression

(2015) Siyuan Dong et al.   Journal of Hematology & Oncology

Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway

(2015) YANG XIA et al.   Molecular Medicine Reports

Long non-coding RNA HOTAIR: A novel oncogene (Review)

(2015) XIN YU et al.   Molecular Medicine Reports

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

(2015) Kari R. Fischer et al.   NATURE

Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer

(2015) Ningning Cheng et al.   Oncotarget

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors

(2014) Christian Rolfo et al.   CANCER TREATMENT REVIEWS

LincRNA-p21 Activates p21 In cis to Promote Polycomb Target Gene Expression and to Enforce the G1/S Checkpoint

(2014) Nadya Dimitrova et al.   MOLECULAR CELL

Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer

(2014) NINGNING CHENG et al.   ONCOLOGY REPORTS

miR-511 induces the apoptosis of radioresistant lung adenocarcinoma cells by triggering BAX

(2014) HAN-HAN ZHANG et al.   ONCOLOGY REPORTS

Long Noncoding RNAs Expression Patterns Associated with Chemo Response to Cisplatin Based Chemotherapy in Lung Squamous Cell Carcinoma Patients

(2014) Zhibo Hou et al.   PLoS One

The chemosensitivity of testicular germ cell tumors

(2014) Ioannis A. Voutsadakis   CELLULAR ONCOLOGY

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer

(2014) Wenrui Duan et al.   Frontiers in Oncology

Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds

(2013) Timur R Samatov et al.   Molecular Cancer

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

(2013) Alice T. Shaw et al.   NEW ENGLAND JOURNAL OF MEDICINE

Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients

(2013) FENG GAO et al.   ONCOLOGY REPORTS

Genome Regulation by Long Noncoding RNAs

(2012) John L. Rinn et al.   Annual Review of Biochemistry

The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells

(2012) T. Gutschner et al.   CANCER RESEARCH

Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

(2012) Limin Xia et al.   HEPATOLOGY

Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition

(2012) Liang Ying et al.   Molecular BioSystems

Landscape of transcription in human cells

(2012) Sarah Djebali et al.   NATURE

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer

(2012) King Pan Ng et al.   NATURE MEDICINE

FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling

(2012) J Wang et al.   ONCOGENE

Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome Gefitinib-resistance in non-small cell lung cancer cell lines

(2011) H Li et al.   Advances in Medical Sciences

Lung cancer: New biological insights and recent therapeutic advances

(2011) Suresh S. Ramalingam et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Metastasis and AKT activation

(2011) Meng Qiao et al.   CELL CYCLE

Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells

(2011) Junjun Chen et al.   CHEMISTRY & BIOLOGY

Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib

(2011) Kenichi Suda et al.   Journal of Thoracic Oncology

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

(2011) L. V. Sequist et al.   Science Translational Medicine

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Long Noncoding RNAs with Enhancer-like Function in Human Cells

(2010) Ulf Andersson Ørom et al.   CELL

Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆

(2010) Sanjeevani Arora et al.   DNA REPAIR

Myristoylated Naked2 Antagonizes Wnt-β-Catenin Activity by Degrading Dishevelled-1 at the Plasma Membrane

(2010) Tianhui Hu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis

(2010) Zchong-Zcho Wu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC

(2010) Alex Chang   LUNG CANCER

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

(2009) A F Gazdar   ONCOGENE

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations

(2008) S. Yano et al.   CANCER RESEARCH

Homologous recombination in DNA repair and DNA damage tolerance

(2008) Xuan Li et al.   CELL RESEARCH

UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion

(2008) Fan Wang et al.   FEBS LETTERS